Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
FORM 8-K
 
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of report (date of earliest event reported): September 20, 2016
 
 
CORE LABORATORIES N.V.
(Exact name of registrant as specified in its charter)
001-14273
(Commission File Number)
The Netherlands
Not Applicable
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
 
 
Strawinskylaan 913
 
Tower A, Level 9
 
1077 XX Amsterdam
 
The Netherlands
Not Applicable
(Address of principal executive offices)
(Zip Code)
 
 
Registrant's telephone number, including area code: (31-20) 420-3191
 
Check the appropriate below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
 
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 
 
 
 
 
 










Item 7.01 Regulation FD

On September 20, 2016, Core Laboratories N.V. (the “Company”) issued a press release announcing that our Chairman and CEO, David M. Demshur, will be speaking at the Johnson Rice Energy Conference in New Orleans, Louisiana on September 21, 2016. He will be delivering our standard corporate presentation, which is presently available on our website, http://www.corelab.com/investors, and making related remarks and is scheduled to start at 10:30 a.m. CDT. His presentation and remarks will be broadcast in real-time on the same website. Mr. Demshur will also be providing prepared answers to a series of questions that have been submitted by the Conference. The prepared answers to the submitted questions are attached to the press release being issued today and are available on our website, http://www.corelab.com/investors.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 7.01 (including the exhibit) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits
    
 
(d)
 
Exhibits
99.1         Press release issued on September 20, 2016 *

* This exhibit is intended to be furnished and shall not be deemed "filed" for purposes of the Exchange Act.









SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 
 
 
Core Laboratories N.V.
 
 
 
 
 
 
 
Dated: September 20, 2016
 
By
 
/s/ Richard L. Bergmark
 
 
 
 
 
 
Richard L. Bergmark
 
 
 
 
 
 
Chief Financial Officer
 
 
 


































CORE LABORATORIES N.V.
EXHIBIT INDEX TO FORM 8-K
 
 
 
 
 
 
EXHIBIT NO.
 
ITEM
 
 
 
99.1
 
Press release issued on September 20, 2016 *
* This exhibit is intended to be furnished and shall not be deemed "filed" for purposes of the Exchange Act.